Impact of Growth Factors and Bone Age on <scp>BMD</scp> in Children and Adolescents With Cerebral Palsy

Children with CP had lower bone age than chronological age. BMD was positively associated with IGF-1 and IGFBP-3 adjusted for bone age. These findings are useful in growth hormone and osteoporosis treatment, such as Zoledronate, in CP.

Authors

Institutions

Publication Details

Journal
Acta Paediatrica
Published
2026-01-07
DOI
https://doi.org/10.1111/apa.70405
Primary Topic
Cerebral Palsy and Movement Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Impact of Growth Factors and Bone Age on BMD in Children and Adolescents With Cerebral Palsy

Michael Lynge Pedersen, Christina Engel Hoei‐Hansen, Reem Zaabalawi, N. Debes et al.
Acta Paediatrica
Cerebral Palsy and Movement Disorders
article

Impact of Growth Factors and Bone Age on BMD in Children and Adolescents With Cerebral Palsy

Michael Lynge Pedersen, Christina Engel Hoei‐Hansen, Reem Zaabalawi, N. Debes, Jesper Johannesen
article en

Abstract

Children with CP had lower bone age than chronological age. BMD was positively associated with IGF-1 and IGFBP-3 adjusted for bone age. These findings are useful in growth hormone and osteoporosis treatment, such as Zoledronate, in CP.

Acta PaediatricaVol. 115(4)
University of Copenhagen (DK), Steno Diabetes Centers (DK), Herlev Hospital (DK), Copenhagen University Hospital (DK), Rigshospitalet (DK)
Openalex Percentile: Top 95%
Cerebral Palsy and Movement Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.